[HTML][HTML] Estimating risk of antidepressant withdrawal from a review of published data

MA Horowitz, A Framer, MP Hengartner, A Sørensen… - CNS drugs, 2023 - Springer
Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The
outcome of adaptation is often referred to as 'physical dependence'in pharmacology, as …

Clozapine discontinuation withdrawal symptoms in schizophrenia

G Blackman, E Oloyede - Therapeutic Advances in …, 2021 - journals.sagepub.com
Clozapine is an atypical antipsychotic used in treatment-resistant schizophrenia. Whilst
clozapine is highly effective, there are some clinical scenarios, such as the emergence of …

A method for tapering antipsychotic treatment that may minimize the risk of relapse

MA Horowitz, S Jauhar, S Natesan… - Schizophrenia …, 2021 - academic.oup.com
The process of stopping antipsychotics may be causally related to relapse, potentially linked
to neuroadaptations that persist after cessation, including dopaminergic hypersensitivity …

Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial

N Morant, M Long, S Jayacodi, R Cooper… - …, 2023 - thelancet.com
Background Antipsychotics are a core treatment for psychosis, but the evidence for gradual
dose reductions guided by clinicians is under-developed. The RADAR randomised …

The human neurosecretome: Extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications

T Soleymani, TY Chen, E Gonzalez-Kozlova… - Frontiers in Molecular …, 2023 - frontiersin.org
Emerging evidence suggests that brain derived extracellular vesicles (EVs) and particles
(EPs) can cross blood-brain barrier and mediate communication among neurons, astrocytes …

Management of antipsychotics in primary care: Insights from healthcare professionals and policy makers in the United Kingdom

AA Woodall, AS Abuzour, SA Wilson, FS Mair, I Buchan… - Plos one, 2024 - journals.plos.org
Introduction Antipsychotic medication is increasingly prescribed to patients with serious
mental illness. Patients with serious mental illness often have cardiovascular and metabolic …

Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia

RE Cooper, JP Mason, T Calton, J Richardson… - Psychosis, 2021 - Taylor & Francis
The development of severe mental health conditions is strongly linked to our environments,
particularly experiences of trauma and adversity. However treatments for severe mental …

Tapering antipsychotic medication: practical considerations

MA Horowitz, J Moncrieff, L de Haan… - Psychological …, 2022 - cambridge.org
Antipsychotic medications are the gold-standard treatment for psychotic patients, and their
efficacy is evident (Kahn et al., 2018). Most guidelines recommend long-term, continuous …

[HTML][HTML] The experiences of 585 people when they tried to withdraw from antipsychotic drugs

J Read - Addictive behaviors reports, 2022 - Elsevier
Introduction Many recipients of antipsychotic drugs try to stop taking them, primarily because
of distressing adverse effects. Little research has been undertaken into the withdrawal …

A scoping review: Treatment attitudes and adherence for adults with schizophrenia

S Nyanyiwa, K Peters, G Murphy - Journal of clinical nursing, 2022 - Wiley Online Library
Aim and objectives This scoping review presents an exploration of literature on the
relationship between treatment attitudes and adherence in adults experiencing …